Pfizer to apply for COVID-19 vaccine EUA after mid-November safety data milestone
Pfizer’s CEO says the company will apply for Emergency Use Authorisation (EUA) for its COVID-19 vaccine candidate ‘soon after’ a safety milestone is reached in the third week of November.